Network for the Evaluation of Vaccine Effectiveness in Latin America and the Caribbean - influenza (REVELAC-i)

Influenza in the Americas causes significant deaths, especially in seniors and young children. Effective vaccines are crucial, but their composition must be updated annually due to viral changes. The REVELAC-i network, established by PAHO and CDC to evaluate influenza vaccine effectiveness across Latin America and the Caribbean, is an initiative that aims to improve public health decisions by generating data on vaccine performance and impact, ultimately reducing influenza morbidity and mortality. Learn about influenza prevention, vaccine effectiveness, and regional efforts to combat the virus.